Advertisement

Topics

Veeva Announces Fiscal 2018 Second Quarter Results

16:05 EDT 24 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Total Revenues of $166.6M, up 27% Year-Over-Year Subscription Services Revenues of $134.3M, up 28% Year-Over-Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life s...

Other Sources for this Article

Investor Relations Contact:
Veeva Systems Inc.
Rick Lund, 925-271-9816
ir@veeva.com
or
Media Contact:
Veeva Systems Inc.
Roger Villareal, 925-264-8885
pr@veeva.com

NEXT ARTICLE

More From BioPortfolio on "Veeva Announces Fiscal 2018 Second Quarter Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...